The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Biocompatible Polymer Nanoparticles for Drug Delivery Applications in Cancer and Neurodegenerative Disorder Therapies
Open accessAbstract
Polymer nanoparticles (NPs) represent one of the most innovative non-invasive approaches for drug delivery applications. NPs main objective is to convey the therapeutic molecule be they drugs, proteins, or nucleic acids directly into the target organ or tissue. Many polymers are used for the synthesis of NPs and among the currently most employed materials several biocompatible synthetic polymers, namely polylactic acid (PLA), poly lactic-co-glycolic acid (PLGA), and polyethylene glycol (PEG), can be cited. These molecules are made of simple monomers which are naturally present in the body and therefore easily excreted without being toxic. The present review addresses the different approaches that are most commonly adopted to synthetize biocompatible NPs to date, as well as the experimental strategies designed to load them with therapeutic agents. In fact, drugs may be internalized in the NPs or physically dispersed therein. In this paper the various types of biodegradable polymer NPs will be discussed with emphasis on their applications in drug delivery. Close attention will be devoted to the treatment of cancer, where both active and passive targeting is used to enhance efficacy and reduce systemic toxicity, and to diseases affecting the central nervous system, inasmuch as NPs can be modified to target specific cells or cross membrane barriers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816 · cited 5×
“Depending on the nozzle size, flow rate, and solution viscosity, the properties of polymer NPs can be controlled [7,13].”
BackgroundInfluentialLong-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Biomedical applications of biodegradable polymers
Ulery, B. D., Nair, L. S., & Laurencin, C. T. (2011) · Journal of Polymer Science Part B: Polymer Physics · doi:10.1002/polb.22259 · Cited by 2,206 · cited 2×
“The use of biod gra able NPs is therefore aimed at “drug targeting”, that is, the selective transp t of a therapeutic age t to i s action site independently of the compartment r th m tho of administration [6].”
BackgroundTumor delivery of macromolecular drugs based on the EPR effect
Torchilin, V. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.011 · Cited by 2,032
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
Structure and design of polymeric surfactant-based drug delivery systems
Torchilin, V. P. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00299-1 · Cited by 1,822
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
Polymer nanoparticles: Preparation techniques and size-control parameters
Rao, J. P., & Geckeler, K. E. (2011) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.01.001 · Cited by 1,725
Gref, R., Lück, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S., Blunk, T., & Müller, R. H. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00156-3 · Cited by 1,723
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,495
Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging
Parveen, S., Misra, R., & Sahoo, S. K. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.05.016 · Cited by 1,436
Biodegradable nanoparticles for drug delivery and targeting
Hans, M. L., & Lowman, A. M. (2002) · Current Opinion in Solid State and Materials Science · doi:10.1016/s1359-0286(02)00117-1 · Cited by 1,324
Nanotech approaches to drug delivery and imaging
Sahoo, S. K., & Labhasetwar, V. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02903-9 · Cited by 1,203
Letchford, K., & Burt, H. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.11.009 · Cited by 1,143
Fleige, E., Quadir, M. A., & Haag, R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.020 · Cited by 1,111
Nanoparticles for drug delivery: The need for precision in reporting particle size parameters
Gaumet, M., Vargas, A., Gurny, R., & Delie, F. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.08.001 · Cited by 1,081
Multidrug resistance (MDR) in cancer
Krishna, R., & Mayer, L. D. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00114-7 · Cited by 1,026
Nanoencapsulation Techniques for Food Bioactive Components: A Review
Ezhilarasi, P. N., Karthik, P., Chhanwal, N., & Anandharamakrishnan, C. (2013) · Food and Bioprocess Technology · doi:10.1007/s11947-012-0944-0 · Cited by 990
Nanomedicine: Developing smarter therapeutic and diagnostic modalities☆
FAROKHZAD, O., & LANGER, R. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.011 · Cited by 800
Torchilin, V. P. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00166-4 · Cited by 680
Adams, G. P., Schier, R., McCall, A. M., Simmons, H. H., Horak, E. M., Alpaugh, R. K., Marks, J. D., & Weiner, L. M. (2001) · PubMed · Cited by 629
Smart polymers for the controlled delivery of drugs – a concise overview
Priya James, H., John, R., Alex, A., & Anoop, K. R. (2014) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2014.02.005 · Cited by 590
Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery
Guo, J., Gao, X., Su, L., Xia, H., Gu, G., Pang, Z., Jiang, X., Yao, L., Chen, J., & Chen, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.004 · Cited by 566
Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?
Kreuter, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.008 · Cited by 554
“SMART” Drug Delivery Systems: Double-Targeted pH-Responsive Pharmaceutical Nanocarriers
Sawant, R. M., Hurley, J. P., Salmaso, S., Kale, A., Tolcheva, E., Levchenko, T. S., & Torchilin, V. P. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060080h · Cited by 540
Biopolymer-based nanoparticles and microparticles: Fabrication, characterization, and application
Joye, I. J., & McClements, D. J. (2014) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2014.07.002 · Cited by 527
Polymer Scaffolds for Biomaterials Applications
Shoichet, M. S. (2010) · Macromolecules · doi:10.1021/ma901530r · Cited by 468
Chen, W., Meng, F., Cheng, R., & Zhong, Z. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.09.023 · Cited by 458
Woodrow, K. A., Cu, Y., Booth, C. J., Saucier-Sawyer, J. K., Wood, M. J., & Mark Saltzman, W. (2009) · Nature Materials · doi:10.1038/nmat2444 · Cited by 438
Micro and nano-fabrication of biodegradable polymers for drug delivery
Lu, Y., & Chen, S. C. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.05.002 · Cited by 340
PEGylated PLGA nanoparticles for the improved delivery of doxorubicin
Park, J., Fong, P. M., Lu, J., Russell, K. S., Booth, C. J., Saltzman, W. M., & Fahmy, T. M. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.02.002 · Cited by 339
TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs
Rao, K. S., Reddy, M. K., Horning, J. L., & Labhasetwar, V. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.08.004 · Cited by 314
The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis
Emerich, D. F., & Thanos, C. G. (2006) · Biomolecular Engineering · doi:10.1016/j.bioeng.2006.05.026 · Cited by 312
Sánchez-López, E., Ettcheto, M., Egea, M. A., Espina, M., Cano, A., Calpena, A. C., Camins, A., Carmona, N., Silva, A. M., Souto, E. B., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0356-z · Cited by 291
Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy
Demento, S. L., Eisenbarth, S. C., Foellmer, H. G., Platt, C., Caplan, M. J., Mark Saltzman, W., Mellman, I., Ledizet, M., Fikrig, E., Flavell, R. A., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.034 · Cited by 290
Emilienne Soma, C., Dubernet, C., Bentolila, D., Benita, S., & Couvreur, P. (2000) · Biomaterials · doi:10.1016/s0142-9612(99)00125-8 · Cited by 281
Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy
Fan, Y., & Moon, J. (2015) · Vaccines · doi:10.3390/vaccines3030662 · Cited by 275
Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer's disease mice
Zhang, C., Wan, X., Zheng, X., Shao, X., Liu, Q., Zhang, Q., & Qian, Y. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.063 · Cited by 262
Beck, R. C. R., Chaves, P. S., Goyanes, A., Vukosavljevic, B., Buanz, A., Windbergs, M., Basit, A. W., & Gaisford, S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.05.074 · Cited by 249
Tosi, G., Costantino, L., Rivasi, F., Ruozi, B., Leo, E., Vergoni, A. V., Tacchi, R., Bertolini, A., Vandelli, M. A., & Forni, F. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.022 · Cited by 234
Drug targeting and tumor heterogeneity
Bae, Y. H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.074 · Cited by 233
Bourdenx, M., Daniel, J., Genin, E., Soria, F. N., Blanchard-Desce, M., Bezard, E., & Dehay, B. (2016) · Autophagy · doi:10.1080/15548627.2015.1136769 · Cited by 215
Hu, D., Chen, L., Qu, Y., Peng, J., Chu, B., Shi, K., Hao, Y., Zhong, L., Wang, M., & Qian, Z. (2018) · Theranostics · doi:10.7150/thno.22989 · Cited by 212
Kim, H., Niu, L., Larson, P., Kucaba, T. A., Murphy, K. A., James, B. R., Ferguson, D. M., Griffith, T. S., & Panyam, J. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.034 · Cited by 210
Design of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer’s disease
Sun, D., Li, N., Zhang, W., Zhao, Z., Mou, Z., Huang, D., Liu, J., & Wang, W. (2016) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2016.08.052 · Cited by 199
Barbara, R., Belletti, D., Pederzoli, F., Masoni, M., Keller, J., Ballestrazzi, A., Vandelli, M. A., Tosi, G., & Grabrucker, A. M. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.05.015 · Cited by 180
Delivery of doxorubicin-loaded PLGA nanoparticles into U87 human glioblastoma cells
Malinovskaya, Y., Melnikov, P., Baklaushev, V., Gabashvili, A., Osipova, N., Mantrov, S., Ermolenko, Y., Maksimenko, O., Gorshkova, M., Balabanyan, V., et al. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.03.049 · Cited by 172
Huang, N., Lu, S., Liu, X.-G., Zhu, J., Wang, Y.-J., & Liu, R.-T. (2017) · Oncotarget · doi:10.18632/oncotarget.20944 · Cited by 170
Polymers in Drug Delivery—State of the Art and Future Trends
Grund, S., Bauer, M., & Fischer, D. (2011) · Advanced Engineering Materials · doi:10.1002/adem.201080088 · Cited by 165
Bhatt, P., Lalani, R., Vhora, I., Patil, S., Amrutiya, J., Misra, A., & Mashru, R. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.11.048 · Cited by 159
Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases
Cacciatore, I., Ciulla, M., Fornasari, E., Marinelli, L., & Stefano, A. D. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1178237 · Cited by 156
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution
Vergoni, A. V., Tosi, G., Tacchi, R., Vandelli, M. A., Bertolini, A., & Costantino, L. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.02.005 · Cited by 150
Patel, J., Amrutiya, J., Bhatt, P., Javia, A., Jain, M. R., & Misra, A. R. (2018) · Journal of Microencapsulation · doi:10.1080/02652048.2018.1453560 · Cited by 149
Jin, M., Jin, G., Kang, L., Chen, L., Gao, Z., & Huang, W. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s161426 · Cited by 146
Polymeric nanomedicines for image-guided drug delivery and tumor-targeted combination therapy
Lammers, T., Šubr, V., Ulbrich, K., Hennink, W. E., Storm, G., & Kiessling, F. M. (2010) · Nano Today · doi:10.1016/j.nantod.2010.05.001 · Cited by 145
Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers
Geldenhuys, W. J., Mbimba, T., Bui, T., Harrison, K. A., & Sutariya, V. B. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2011.589435 · Cited by 144
Enzyme replacement therapy for lysosomal storage diseases
Lachmann, R. (2011) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32834c20d9 · Cited by 143
Smart polymeric micelles for gene and drug delivery
Nishiyama, N., Bae, Y., Miyata, K., Fukushima, S., & Kataoka, K. (2005) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2005.05.007 · Cited by 132
Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases
Gendelman, H. E., Anantharam, V., Bronich, T. K., Ghaisas, S., Jin, H., Kanthasamy, A. G., Liu, X., McMillan, J., Mosley, R. L., Narasimhan, B., et al. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.12.014 · Cited by 130
pH-Responsive PLGA Nanoparticle for Controlled Payload Delivery of Diclofenac Sodium
Khanal, S., Adhikari, U., Rijal, N. P., Bhattarai, S. R., Sankar, J., & Bhattarai, N. (2016) · Journal of Functional Biomaterials · doi:10.3390/jfb7030021 · Cited by 128
Sanna, V., Singh, C. K., Jashari, R., Adhami, V. M., Chamcheu, J. C., Rady, I., Sechi, M., Mukhtar, H., & Siddiqui, I. A. (2017) · Scientific Reports · doi:10.1038/srep41573 · Cited by 123
Modulation of the Tumor Microenvironment for Cancer Treatment: A Biomaterials Approach
Adjei, I. M., & Sharma, B. (2015) · Journal of Functional Biomaterials · doi:10.3390/jfb6010081 · Cited by 117
Kulkarni, S. A., & Feng, S. (2011) · Nanomedicine · doi:10.2217/nnm.10.131 · Cited by 115
Nanosystems for simultaneous imaging and drug delivery to T cells
Fahmy, T. M., Fong, P., Park, J. Y., Constable, R. T., & Saltzman, W. M. (2007) · The AAPS Journal · doi:10.1208/aapsj0902019 · Cited by 113
Salvalaio, M., Rigon, L., Belletti, D., D’Avanzo, F., Pederzoli, F., Ruozi, B., Marin, O., Vandelli, M. A., Forni, F., Scarpa, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156452 · Cited by 101
Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model
Çırpanlı, Y., Allard-Vannier, É., Passirani, C., Bilensoy, E., Lemaire, L. P., Çalış, S., & Benoît, J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.015 · Cited by 99
Hematopoietic Stem Cell Gene Therapy for Storage Disease: Current and New Indications
Biffi, A. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.025 · Cited by 99
Protein– and Peptide–Drug Conjugates
Vhora, I., Patil, S., Bhatt, P., & Misra, A. R. (2015) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2014.11.001 · Cited by 98
Pharmacokinetics and biodistribution of surface modification polymeric nanoparticles
Liu, M., Li, H., Luo, G., Liu, Q., & Wang, Y. (2008) · Archives of Pharmacal Research · doi:10.1007/s12272-001-1191-8 · Cited by 94
Hu, J., Fu, S., Peng, Q., Han, Y., Xie, J., Zan, N., Chen, Y., & Fan, J. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.11.047 · Cited by 90
Nanotechnology-based drug delivery of ropinirole for Parkinson’s disease
Barcia, E., Boeva, L., García‐García, L., Slowing, K., Fernández-Carballido, A. M., Casanova, Y., & Negro, S. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1359862 · Cited by 84
Ahmad, N., Ahmad, R., Alam, A., & Ahmad, F. J. (2018) · Chemistry Central Journal · doi:10.1186/s13065-018-0434-1 · Cited by 84
Shafiei‐Irannejad, V., Samadi, N., Salehi, R., Yousefi, B., Rahimi, M., Akbarzadeh, A., & Zarghami, N. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2404-7 · Cited by 80
Martino, S., Marconi, P., Tancini, B., Dolcetta, D., Angelis, M. G. C. D., Montanucci, P., Bregola, G., Sandhoff, K., Bordignon, C., Emiliani, C., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi216 · Cited by 75
Self-citationYuan, J., Zhuge, D., Tong, M., Lin, M., Xu, X.-F., Tang, X., Zhao, Y., & Xu, H. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1423495 · Cited by 73
Kuo, Y., & Tsai, H.-C. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.05.062 · Cited by 70
Hekmatara, T., Bernreuther, C., Khalansky, A. S., Theisen, A., Weissenberger, J., Matschke, J., Gelperina, S. E., Kreuter, J., & Glatzel, M. (2009) · Clinical Neuropathology · doi:10.5414/npp28153 · Cited by 61
Kuo, Y., & Rajesh, R. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.05.039 · Cited by 54
Polchi, A., Magini, A., Mazuryk, J., Tancini, B., Gapiński, J., Patkowski, A., Giovagnoli, S., & Emiliani, C. (2016) · Nanomaterials · doi:10.3390/nano6050087 · Cited by 49
Self-citationMuro, S. (2012) · Drug Delivery and Translational Research · doi:10.1007/s13346-012-0072-4 · Cited by 47
Enzyme replacement therapy for lysosomal storage diseases.
Ohashi, T. (2012) · PubMed · Cited by 45
Potential of surfactant-coated nanoparticles to improve brain delivery of arylsulfatase A
Schuster, T., Mühlstein, A., Yaghootfam, C., Maksimenko, O., Шипуло, Е. В., Gelperina, S. E., Kreuter, J., Gieselmann, V., & Matzner, U. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.016 · Cited by 44
Kong, N., Deng, M., Sun, X., Chen, Y., & Sui, X. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00125 · Cited by 44
Bourgoin, C., Emiliani, C., Kremer, E. J., Gélot, A., Tancini, B., Gravel, R. A., Drugan, C., Orlacchio, A., Poënaru, L., & Caillaud, C. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302081 · Cited by 41
Self-citationArfı, A., Bourgoin, C., Basso, L., Emiliani, C., Tancini, B., Chigorno, V., Li, Y., Orlacchio, A., Poënaru, L., Sonnino, S., et al. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.04.017 · Cited by 36
Self-citationMartín‐Banderas, L., Holgado, M. A., Durán‐Lobato, M., Infante, J. J., Álvarez‐Fuentes, J., & Arévalo, M. F. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160210130608 · Cited by 36
Tancini, B., Tosi, G., Barbara, B., Dolcetta, D., Magini, A., Martino, E. D., Urbanelli, L., Ruozi, B., Forni, F., Emiliani, C., et al. (2014) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2015.9251 · Cited by 34
Self-citationRecent Developments in Therapeutic Approaches for Lysosomal Storage Diseases
Urbanelli, L., Magini, A., Polchi, A., Polidoro, M., & Emiliani, C. (2010) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488911794079127 · Cited by 22
Self-citationDonida, B., Tauffner, B., Raabe, M., Immich, M. F., de Farias, M. A., Coutinho, D. D. S., Machado, A. Z., Kessler, R. G., Portugal, R. V., Bernardi, A., et al. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.10.005 · Cited by 22
Hu, P., Li, Y., Nikolaishvili‐Feinberg, N., Scesa, G., Bi, Y., Pan, D., Moore, D. T., Bongarzone, E. R., Sands, M. S., Miller, C. R., et al. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23847 · Cited by 20
Cited by
Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology
Zielińska, A., Carreiró, F., Oliveira, A. M., Neves, A., Pires, B., Venkatesh, D. N., Durazzo, A., Lucarini, M., Eder, P., Silva, A. M., et al. (2020) · Molecules · doi:10.3390/molecules25163731 · Cited by 1,560
Polymeric Nanoparticles for Drug Delivery: Recent Developments and Future Prospects
Begines, B., Ortiz, T., Pérez-Aranda, M., Martínez, G., Merinero, M., Argüelles-Arias, F., & Alcudia, A. (2020) · Nanomaterials · doi:10.3390/nano10071403 · Cited by 1,061
PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application
Su, Y., Zhang, B., Sun, R., Liu, W., Zhu, Q., Zhang, X., Wang, R., & Chen, C. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1938756 · Cited by 617
Brown, T. P., & Ganapathy, V. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107451 · Cited by 481
Emerging trends in the novel drug delivery approaches for the treatment of lung cancer
Sharma, P., Mehta, M., Dhanjal, D. S., Kaur, S., Gupta, G., Singh, H., Thangavelu, L., Rajeshkumar, S., Tambuwala, M., Bakshi, H. A., et al. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.06.033 · Cited by 430
Metadata
- Authors
- Calzoni, E., Cesaretti, A., Polchi, A., Di Michele, A., Tancini, B., & Emiliani, C.
- Venue
- Journal of Functional Biomaterials
- Publisher
- MDPI AG
- Published
- 2019-01-08
- Volume
- 10
- Issue
- 1
- Pages
- 4
- ISSN
- 2079-4983 (ISSN-L)
- OpenAlex
- W2910966398
- Cited by
- 468
- References
- 94
- FWCI
- 14.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.